China’s Rise in Drug Development Looms Over U.S.
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
China's rapidly expanding biotechnology sector is drawing significant international attention, particularly at a recent oncology conference in Chicago. The rapid growth has raised concerns among observers about the potential shift in global leadership within the pharmaceutical and drug development landscape. This development suggests a changing dynamic in the industry, with China emerging as a major player.
This matters because it could impact the future of medical innovation and the global supply chain for new treatments.
📌 Kaynak
Bu özet NYT Science kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →